Killen Group’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | $228K | Buy |
40,000
+9,000
| +29% | +$51.3K | 0.03% | 108 |
|
|
2015
Q4 | $322K | Buy |
31,000
+1,000
| +3% | +$10.4K | 0.03% | 100 |
|
|
2015
Q3 | $554K | Sell |
30,000
-4,600
| -13% | -$84.9K | 0.05% | 90 |
|
|
2015
Q2 | $673K | Hold |
34,600
| – | – | 0.05% | 88 |
|
|
2015
Q1 | $608K | Hold |
34,600
| – | – | 0.04% | 94 |
|
|
2014
Q4 | $553K | Hold |
34,600
| – | – | 0.04% | 94 |
|
|
2014
Q3 | $436K | Hold |
34,600
| – | – | 0.02% | 110 |
|
|
2014
Q2 | $540K | Hold |
34,600
| – | – | 0.03% | 107 |
|
|
2014
Q1 | $454K | Hold |
34,600
| – | – | 0.02% | 107 |
|
|
2013
Q4 | $556K | Buy |
34,600
+4,600
| +15% | +$73.9K | 0.03% | 108 |
|
|
2013
Q3 | $499K | Buy |
30,000
+10,000
| +50% | +$166K | 0.03% | 106 |
|
|
2013
Q2 | $201K | Buy |
+20,000
| New | +$201K | 0.01% | 108 |
|